180 related articles for article (PubMed ID: 1416845)
21. Antimicrobial susceptibilities of southern African isolates of Haemophilus ducreyi.
Dangor Y; Miller SD; Exposto Fda L; Koornhof HJ
Antimicrob Agents Chemother; 1988 Sep; 32(9):1458-60. PubMed ID: 3264133
[TBL] [Abstract][Full Text] [Related]
22. Common beta-lactamase-specifying plasmid in Haemophilus ducreyi and Neisseria gonorrhoeae.
Anderson B; Albritton WL; Biddle J; Johnson SR
Antimicrob Agents Chemother; 1984 Feb; 25(2):296-7. PubMed ID: 6424563
[TBL] [Abstract][Full Text] [Related]
23. Comparison of antimicrobial susceptibility patterns of fifty-seven strains of Haemophilus ducreyi isolated in Amsterdam from 1978 to 1985.
Sturm AW
J Antimicrob Chemother; 1987 Feb; 19(2):187-91. PubMed ID: 3494720
[TBL] [Abstract][Full Text] [Related]
24. Antimicrobial susceptibilities of Neisseria gonorrhoeae strains representing five distinct resistance phenotypes.
Rice RJ; Knapp JS
Antimicrob Agents Chemother; 1994 Jan; 38(1):155-8. PubMed ID: 8141573
[TBL] [Abstract][Full Text] [Related]
25. In vitro activities of U-63366, a spectinomycin analog; roxithromycin (RU 28965), a new macrolide antibiotic; and five quinolone derivatives against Haemophilus ducreyi.
Sanson-Le Pors MJ; Casin IM; Thebault MC; Arlet G; Perol Y
Antimicrob Agents Chemother; 1986 Sep; 30(3):512-3. PubMed ID: 2946262
[TBL] [Abstract][Full Text] [Related]
26. The treatment of chancroid.
Schmid GP
JAMA; 1986 Apr; 255(13):1757-62. PubMed ID: 3512872
[TBL] [Abstract][Full Text] [Related]
27. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from symptomatic men attending the Nanjing sexually transmitted diseases clinic (2011-2012): genetic characteristics of isolates with reduced sensitivity to ceftriaxone.
Li S; Su XH; Le WJ; Jiang FX; Wang BX; Rice PA
BMC Infect Dis; 2014 Nov; 14():622. PubMed ID: 25427572
[TBL] [Abstract][Full Text] [Related]
28. Novel plasmid combinations in Haemophilus ducreyi isolates from Thailand.
Sarafian SK; Johnson SR; Thomas ML; Knapp JS
J Clin Microbiol; 1991 Oct; 29(10):2333-4. PubMed ID: 1939592
[TBL] [Abstract][Full Text] [Related]
29. Molecular epidemiology, in 1994, of Neisseria gonorrhoeae in Manila and Cebu City, Republic of the Philippines.
Knapp JS; Mesola VP; Neal SW; Wi TE; Tuazon C; Manalastas R; Perine PL; Whittington WL
Sex Transm Dis; 1997 Jan; 24(1):2-7. PubMed ID: 9018776
[TBL] [Abstract][Full Text] [Related]
30. Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers.
Appelbaum PC; Spangler SK; Jacobs MR
Antimicrob Agents Chemother; 1990 Aug; 34(8):1546-50. PubMed ID: 2221864
[TBL] [Abstract][Full Text] [Related]
31. Molecular epidemiology of beta-lactamase-specifying plasmids of Haemophilus ducreyi.
Brunton J; Meier M; Ehrman N; Maclean I; Slaney L; Albritton WL
Antimicrob Agents Chemother; 1982 Jun; 21(6):857-63. PubMed ID: 6287927
[TBL] [Abstract][Full Text] [Related]
32. Comparative study of ceftriaxone and trimethoprim-sulfamethoxazole for the treatment of chancroid in Thailand.
Taylor DN; Pitarangsi C; Echeverria P; Panikabutra K; Suvongse C
J Infect Dis; 1985 Nov; 152(5):1002-6. PubMed ID: 3876396
[TBL] [Abstract][Full Text] [Related]
33. Failure of treatment for chancroid in Rwanda is not related to human immunodeficiency virus infection: in vitro resistance of Haemophilus ducreyi to trimethoprim-sulfamethoxazole.
Bogaerts J; Kestens L; Martinez Tello W; Akingeneye J; Mukantabana V; Verhaegen J; Van Dyck E; Piot P
Clin Infect Dis; 1995 Apr; 20(4):924-30. PubMed ID: 7795096
[TBL] [Abstract][Full Text] [Related]
34. In vitro activity of orally administered antimicrobial agents against Haemophilus influenzae recovered from children monitored longitudinally in a group day-care center.
George MJ; Kitch B; Henderson FW; Gilligan PH
Antimicrob Agents Chemother; 1991 Oct; 35(10):1960-4. PubMed ID: 1759814
[TBL] [Abstract][Full Text] [Related]
35. In vitro susceptibilities of 126 clinical isolates of Yersinia enterocolitica to 21 beta-lactam antibiotics.
Hornstein MJ; Jupeau AM; Scavizzi MR; Philippon AM; Grimont PA
Antimicrob Agents Chemother; 1985 May; 27(5):806-11. PubMed ID: 2990327
[TBL] [Abstract][Full Text] [Related]
36. A comparison of the in vitro activity of rosamicin, erythromycin, clindamycin, metroidazole and ornidazole against Haemophilus ducreyi, including beta-lactamase producing strains.
Feltham S; Ronald AR; Albritton WL
J Antimicrob Chemother; 1979 Nov; 5(6):731-4. PubMed ID: 317079
[No Abstract] [Full Text] [Related]
37. Treatment of chancroid, 1989.
Schmid GP
Rev Infect Dis; 1990; 12 Suppl 6():S580-9. PubMed ID: 2201074
[TBL] [Abstract][Full Text] [Related]
38. The comparative in-vitro activity of twelve 4-quinolone antimicrobials against Haemophilus ducreyi.
Wall RA; Mabey DC; Bello CS; Felmingham D
J Antimicrob Chemother; 1985 Aug; 16(2):165-8. PubMed ID: 3877717
[TBL] [Abstract][Full Text] [Related]
39. Susceptibility of twenty penicillin-susceptible and -resistant pneumococci to levofloxacin, ciprofloxacin, ofloxacin, erythromycin, azithromycin, and clarithromycin by MIC and time-kill.
Visalli MA; Jacobs MR; Appelbaum PC
Diagn Microbiol Infect Dis; 1997 Jul; 28(3):131-7. PubMed ID: 9294703
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the Etest with agar dilution for antimicrobial susceptibility testing of Haemophilus ducreyi.
Lagergård T; Frisk A; Trollfors B
J Antimicrob Chemother; 1996 Nov; 38(5):849-52. PubMed ID: 8961054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
